PUBLISHED: 2014
CATEGORY: Health care providers
TYPE: External Link The Recommended Use of the Multicomponent Meningococcal B (4CMenB) Vaccine in Canada
The Recommended Use of the Multicomponent Meningococcal B (4CMenB) Vaccine in Canada The Recommended Use of the Multicomponent Meningococcal B (4CMenB) Vaccine in Canada
The NACI Statement, presented as Part 1, and the programmatic chapters, presented as Part 2, have been combined together and are considered the Common Guidance for the recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada.
Corporate Authors: National Advisory Committee on Immunization
Publisher: Publisher
Public Health Agency of Canada
